ADMA Biologics ADMA Plasma Collection Centers — Total Assets

Other segment segments

Similar metrics at other companies

HAEPlasma — Total long-lived assets

$206.37M+8.7%

HAEBlood Center — Total long-lived assets

$39.68M-1.6%

HAEPlasma products and services — D&A

$11.53M-4.4%

HAEPlasma — Cost of goods sold

$54.39M+14.9%

HAEPlasma — Total net revenues

$130.29M+2.8%

HAEPlasma — Costs incurred, net of reversals

$0—

Questions, answered.

What is ADMA Biologics's plasma collection centers — total assets?

ADMA Biologics (ADMA) reported plasma collection centers — total assets of $25.26M in Q1 2026.

How has ADMA Biologics's plasma collection centers — total assets changed year-over-year?

ADMA Biologics's plasma collection centers — total assets decreased by 8.6% year-over-year, from $27.64M to $25.26M.

What is the long-term trend for ADMA Biologics's plasma collection centers — total assets?

Over 4 years (2021 to 2025), ADMA Biologics's plasma collection centers — total assets has grown at a 7.2% compound annual growth rate (CAGR), from $84.95M to $112.33M.

What does plasma collection centers — total assets mean?

This metric reflects the total book value of assets directly attributable to the plasma collection segment, including property, plant, equipment, and intangible assets. It provides a measure of the capital base required to maintain and operate the collection network. Tracking this asset base helps evaluate the efficiency of capital utilization within the segment.